NBIX

Neurocrine Biosciences
D

NBIX

132.960
USD
1.65
(1.26%)
مغلق
حجم التداول
21,515
الربح لكل سهم
5
العائد الربحي
-
P/E
39
حجم السوق
13,187,173,570
أصول ذات صلة
ALNY
ALNY
6.65
(1.50%)
449.19 USD
AMGN
AMGN
6.28
(2.16%)
296.49 USD
A
ARWR
1.730
(9.21%)
20.510 USD
BIIB
BIIB
3.680
(2.73%)
138.670 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
ILMN
ILMN
-0.005
(-0.01%)
100.105 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
S
SGMO
0.02420
(4.37%)
0.57800 USD
S
SRPT
1.500
(7.39%)
21.810 USD
VRTX
VRTX
2.49
(0.64%)
392.97 USD
المزيد
الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.